Aayush Wellness Stock Reaches All-Time High, Outperforms Sector and Sensex

Aug 31 2024 09:20 AM IST
share
Share Via
Aayush Wellness, a microcap pharmaceutical company, has seen a significant increase in its stock price, reaching an all-time high on August 31, 2024. The company's stock has been on a steady upward trend for the past 20 days, gaining 55.63% in returns. Despite a 'Sell' rating from MarketsMojo, Aayush Wellness has outperformed the sector and the Sensex, showcasing its strong growth potential and impressive performance in the stock market.
Aayush Wellness Stock Reaches All-Time High, Outperforms Sector and Sensex
Aayush Wellness, a microcap pharmaceutical company, has been making headlines in the stock market as its stock price reached an all-time high on August 31, 2024. The company's stock has been on an upward trend for the past 20 days, gaining an impressive 55.63% in returns during this period. This has caught the attention of investors and analysts alike. According to MarketsMOJO, a leading stock market analysis platform, the current stock call for Aayush Wellness is 'Sell'. However, the company's performance today has outperformed the sector by 0.55%, indicating a positive outlook for the company. In today's trading session, Aayush Wellness hit a new 52-week high of Rs.45.6, further boosting investor confidence. The company's stock is also trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong bullish trend. In terms of overall performance, Aayush Wellness has outperformed the Sensex by a staggering 1642.45% in the past year, while the Sensex has only seen a 26.55% increase. This showcases the company's strong growth potential and its ability to deliver impressive returns to its shareholders. As a microcap company, Aayush Wellness may not be on the radar of many investors, but its recent performance in the stock market is certainly worth noting. With a strong upward trend and impressive returns, Aayush Wellness is definitely a company to keep an eye on in the pharmaceutical industry.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News